• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

14
1
1
1

COUNTRY

1

CATEGORIES

  • 14
  • 7
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

14
18
20
43

PUBLISHED

0
0
3
43

PRODUCT TYPE

34
9

Search "TheraGenetics Inc. - Product Pipeline Analysis" returned 43 results.

Expression Genetics, Inc. - Product Pipeline Review - Q4 2010

Expression Genetics, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Expression Genetics, Inc. - Product Pipeline Review - Q4 2010” provides data on...

November 2010
FROM

Expression Genetics, Inc. - Product Pipeline Review - Q4 2010

Expression Genetics, Inc. – Product Pipeline Review – Q4 2010 Summary Global Market Direct’s pharmaceuticals report, “Expression Genetics, Inc. - Product Pipeline Review - Q4 2010” provides data on...

November 2010
FROM

Gene Therapy Market, 2015 - 2025

Several disorders that arise inside the body are a result of either a direct genetic aberration or a dysfunctional/non-functional protein. The attempt to use nucleic acids to correct or delete the genes...

February 2015
FROM

Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2014 Update

Summary Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the discovery and commercialization of molecular diagnostic tests that assesses person’s risk towards...

May 2014
FROM

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2014

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2014 Summary Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H1 2014’, provides an overview of the B-Cell...

April 2014
FROM

Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis, 2013 Update

Summary Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the development and commercialization of small molecular diagnostic products. The company offers different...

April 2013
FROM

Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review

Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

January 2014
FROM

Myriad Genetics, Inc. (MYGN) - Product Pipeline Analysis

Summary Myriad Genetics, Inc. (Myriad) is a molecular diagnostic company. The company undertakes the development and commercialization of small molecular diagnostic products. The company offers different...

November 2012
FROM

Biomarker Technology Platforms for Cancer Diagnoses and Therapies 2014

Until superior therapeutic treatments are developed to prevent, treat and cure cancer, the best means of reducing mortality and morbidity in a disease this complex is early detection and diagnosis....

July 2014
FROM

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2013', provides an overview of the indication’s...

October 2013
FROM

Companion Diagnostics - Global Strategic Business Report

This report analyzes the worldwide markets for Companion Diagnostics in US$ Thousand The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World Annual estimates...

September 2011
FROM

Alzheimer's Disease - Pipeline Review, H2 2013

'Alzheimer's Disease - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline This report provides information on the therapeutic development for Alzheimer's Disease,...

August 2013
FROM

Everist Genomics, Inc. - Product Pipeline Analysis

Everist Genomics, Inc. - Product Pipeline Analysis Summary Everist Genomics, Inc. (EGI), formerly Genetics Squared, Inc., is a privately held pharmaceutical company that is engaged in the development...

November 2011
FROM

Companion Diagnostics in Personalized Medicine and Cancer Therapy

Companion diagnostics (CDx) refers to a particular clinical diagnostic test that is under evaluation and is specifically linked to a known drug therapy This linkage could be important in the therapeutic...

June 2014
FROM

Large Volume Wearable Injectors - 2nd Edition

The injectable drug delivery market holds significant potential for the future. From the conventional syringes with vials and painful needles to the modern-day pre-filled syringes, pen-injectors, needle...

September 2014
FROM

Follicular Lymphoma - Pipeline Review, H2 2013

Follicular Lymphoma - Pipeline Review, H2 2013 Summary Global Markets Direct’s, 'Follicular Lymphoma - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This...

July 2013
FROM

Stem Cell Markets

A stem cell is an extraordinary type of cell that has the ability to self-renew for long periods of time and to differentiate into specialized cells under appropriate physiological or experimental conditions...

August 2013
FROM

ADHD Therapeutics - Global Strategic Business Report

This report analyzes the worldwide markets for ADHD Therapeutics in US$ Million The report provides separate comprehensive analytics for the US and Rest of World Annual estimates and forecasts are provided...

June 2010
FROM

Non-Hodgkin's Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015

Non-Hodgkin’s Lymphoma (NHL) - Drug Pipeline Analysis and Market Forecasts to 2015 Summary GlobalData, the industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare...

January 2010
FROM

Cancer Therapies - Global Strategic Business Report

This report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy The report provides...

October 2011
FROM
Loading Indicator

Our Clients

NBC Universal Inc. Samsung Group Ltd. E.ON SE DHL International GmbH University of Cambridge Kone Oyj BP Plc.